The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
NCT ID: NCT00212459
Last Updated: 2013-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2005-05-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A
NCT02362581
Individually Tailored Prophylaxis in Patients With Severe Hemophilia A
NCT00995046
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia
NCT02866526
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
NCT00782470
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
NCT03623295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aims of the study are:
* To provide a new method of bleeding and treatment documentation in the home setting (logs) to adolescent subjects with Hemophilia A or B
* To counsel these subjects about adherence to their treatment regimen prescribed by physician and the importance of keeping accurate documentation of each bleeding episode and its treatment.
* To improve maintenance of logs, to allow for 1) assessment of bleeding frequency and treatment efficacy and 2) early detection of target joint bleeding and the potential need for prophylactic factor replacement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients are contacted every two weeks after initial counseling to discuss completion of bleeding records.
Counseling
Patients are contacted every two weeks after initial counseling to discuss the completion of bleeding records.
2
After the initial counseling with regards to bleeding records, there are no more contacts made with the control patients.
Control
No more contacts are made with control patients after the initial counseling session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Counseling
Patients are contacted every two weeks after initial counseling to discuss the completion of bleeding records.
Control
No more contacts are made with control patients after the initial counseling session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Severe or moderate Hemophilia A or B
* Self-infusing or transitioning to self infusion in the home setting
* Already assigned responsibility of monitoring bleeding logs
12 Years
20 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York Presbyterian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
New York Presbyterian Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donna M DiMichele, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NY Presbyterian Hospital
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bleeding Logs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.